Flexion Therapeutics, Inc. (FLXN) Social Stream
Featured Post From StockTwits About FLXN
$FLXN Abstract of article from July 5th sounds like sales are booming!StockDoctorBio, published August 2, 2021
The knee osteoarthritis injection was hit hard by COVID-19 restrictions, at first. But CEO Mike Clayman reflected in an interview about how the pandemic experience is helping fuel further growth for Zilretta.
What Else are FLXN Traders Talking About?
Other Notable StockTweets About FLXN
$FLXN This is sitting at same revenue as december of 2019, still burning through 30 million a quarter (more than sales). I wanted to like this company but I asked a Dr friend head of rehab unit at a hospital about this drug, he told me to stay away. Glad I listened. Don’t be surprised if this goes lower if earnings are anything less than stellargodlords, published July 27, 2021
$FLXN / Flexion Therapeutics files form 8-K - UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 https://fintel.io/sf/us/flxn?utm_source=stocktwits.com&utm_medium=Referral&utm_campaign=filingrisenhoover, published July 12, 2021
Every day I pick 2-5 stocks - the most undervalued stocks in AMEX, NYSE & NASDAQ to trade for the next trading day (in a live youtube stream at 3:30pm NY Time – Link Below). These stocks are generally undervalued following a decline in demand driven by declining investor confidence or their fundamentals improve rapidly while the market price remains almost unchanged. I am targeting a trading goal of 50% return by Dec 31 2021. In 2020 I gained 121%. Below is profit & loss from yesterday's picks. Keep these stocks on your watchlist for the next 1-5 days. Some of them may see huge gains in the next 1-5 days:
$FLXN $CSX $TRP $KOLD